Sun Pharmaceutical Industries Limited
SUNPHARMA
Rang in aandelen
#526
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Aandeelprijs
$19.24
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$46.15B
Verandering (1 dag)
-0.97%
Verandering (1 jaar)
0.11%
Land
IN
Handel Sun Pharmaceutical Industries Limited (SUNPHARMA)
Categorie
Healthcare
Winst voor Sun Pharmaceutical Industries Limited (SUNPHARMA)
Winst in Jun 2026 TTM: $1.76B
Volgens de meest recente financiële verslagen van Sun Pharmaceutical Industries Limited bedraagt de huidige winst van het bedrijf $1.76B. In 2024 behaalde het bedrijf een winst van $1.33B, een stijging ten opzichte van de winst van 2023, die $1.14B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Sun Pharmaceutical Industries Limited van 2004 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $1.76B | 9.86% |
| 2025 | $1.61B | 21.21% |
| 2024 | $1.33B | 16.34% |
| 2023 | $1.14B | 93.65% |
| 2022 | $588.17M | 54.49% |
| 2021 | $380.72M | -42.58% |
| 2020 | $663.01M | 20.88% |
| 2019 | $548.49M | 3.41% |
| 2018 | $530.42M | -62.03% |
| 2017 | $1.40B | 40.80% |
| 2016 | $992.01M | -3.13% |
| 2015 | $1.02B | 33.99% |
| 2014 | $764.30M | -3.90% |
| 2013 | $795.33M | 20.15% |
| 2012 | $661.93M | 44.90% |
| 2011 | $456.82M | 45.01% |
| 2010 | $315.02M | -17.95% |
| 2009 | $383.94M | -3.94% |
| 2008 | $399.69M | 107.87% |
| 2007 | $192.27M | 43.47% |
| 2006 | $134.02M | 39.03% |
| 2005 | $96.39M | 9.76% |
| 2004 | $87.82M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
